These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 16565511)
1. Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Boisvert WA; Rose DM; Johnson KA; Fuentes ME; Lira SA; Curtiss LK; Terkeltaub RA Am J Pathol; 2006 Apr; 168(4):1385-95. PubMed ID: 16565511 [TBL] [Abstract][Full Text] [Related]
2. GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions. Filipovic R; Jakovcevski I; Zecevic N Dev Neurosci; 2003; 25(2-4):279-90. PubMed ID: 12966224 [TBL] [Abstract][Full Text] [Related]
3. Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis. Zernecke A; Weber KS; Erwig LP; Kluth DC; Schröppel B; Rees AJ; Weber C J Immunol; 2001 May; 166(9):5755-62. PubMed ID: 11313419 [TBL] [Abstract][Full Text] [Related]
4. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Wang B; Hendricks DT; Wamunyokoli F; Parker MI Cancer Res; 2006 Mar; 66(6):3071-7. PubMed ID: 16540656 [TBL] [Abstract][Full Text] [Related]
5. CXCR2 is critical to hyperoxia-induced lung injury. Sue RD; Belperio JA; Burdick MD; Murray LA; Xue YY; Dy MC; Kwon JJ; Keane MP; Strieter RM J Immunol; 2004 Mar; 172(6):3860-8. PubMed ID: 15004193 [TBL] [Abstract][Full Text] [Related]
6. Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2. Kershaw MH; Wang G; Westwood JA; Pachynski RK; Tiffany HL; Marincola FM; Wang E; Young HA; Murphy PM; Hwu P Hum Gene Ther; 2002 Nov; 13(16):1971-80. PubMed ID: 12427307 [TBL] [Abstract][Full Text] [Related]
7. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. Huo Y; Weber C; Forlow SB; Sperandio M; Thatte J; Mack M; Jung S; Littman DR; Ley K J Clin Invest; 2001 Nov; 108(9):1307-14. PubMed ID: 11696575 [TBL] [Abstract][Full Text] [Related]
8. CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo. Zhang XW; Liu Q; Wang Y; Thorlacius H Br J Pharmacol; 2001 Jun; 133(3):413-21. PubMed ID: 11375258 [TBL] [Abstract][Full Text] [Related]
9. High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. Spandau UH; Toksoy A; Verhaart S; Gillitzer R; Kruse FE Arch Ophthalmol; 2003 Jun; 121(6):825-31. PubMed ID: 12796254 [TBL] [Abstract][Full Text] [Related]
10. CXC chemokine receptor 2 but not C-C chemokine receptor 1 expression is essential for neutrophil recruitment to the cornea in helminth-mediated keratitis (river blindness). Hall LR; Diaconu E; Patel R; Pearlman E J Immunol; 2001 Mar; 166(6):4035-41. PubMed ID: 11238651 [TBL] [Abstract][Full Text] [Related]
12. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Loukinova E; Dong G; Enamorado-Ayalya I; Thomas GR; Chen Z; Schreiber H; Van Waes C Oncogene; 2000 Jul; 19(31):3477-86. PubMed ID: 10918606 [TBL] [Abstract][Full Text] [Related]
13. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. Boisvert WA; Santiago R; Curtiss LK; Terkeltaub RA J Clin Invest; 1998 Jan; 101(2):353-63. PubMed ID: 9435307 [TBL] [Abstract][Full Text] [Related]
14. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis. Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733 [TBL] [Abstract][Full Text] [Related]
15. Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Henke PK; Varga A; De S; Deatrick CB; Eliason J; Arenberg DA; Sukheepod P; Thanaporn P; Kunkel SL; Upchurch GR; Wakefield TW Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1130-7. PubMed ID: 15105284 [TBL] [Abstract][Full Text] [Related]
16. Developmental expression of two CXC chemokines, MIP-2 and KC, and their receptors. Luan J; Furuta Y; Du J; Richmond A Cytokine; 2001 Jun; 14(5):253-63. PubMed ID: 11444905 [TBL] [Abstract][Full Text] [Related]
17. CXC chemokines and their receptors are expressed in type II cells and upregulated following lung injury. Vanderbilt JN; Mager EM; Allen L; Sawa T; Wiener-Kronish J; Gonzalez R; Dobbs LG Am J Respir Cell Mol Biol; 2003 Dec; 29(6):661-8. PubMed ID: 12829448 [TBL] [Abstract][Full Text] [Related]
18. Modulation of atherogenesis by chemokines. Boisvert WA Trends Cardiovasc Med; 2004 May; 14(4):161-5. PubMed ID: 15177267 [TBL] [Abstract][Full Text] [Related]
19. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. Keane MP; Belperio JA; Xue YY; Burdick MD; Strieter RM J Immunol; 2004 Mar; 172(5):2853-60. PubMed ID: 14978086 [TBL] [Abstract][Full Text] [Related]